Pharmacytimes: Condition Center: Atrial Fibrillation http://www.pharmacytimes.com/condition-resources/afib/condition-rss Atrial Fibrillation en-us Tue, 06 Dec 2016 05:54:08 UTC Tue, 06 Dec 2016 05:54:08 UTC Black Patients Face Greater Risk for Poor Afib Outcomes http://www.pharmacytimes.com/resource-centers/afib/black-patients-face-greater-risk-for-poor-afib-outcomes Black patients with atrial fibrillation are more likely to experience stroke, heart failure, and coronary heart disease than their white counterparts. 10:45 PM, Wed June 29, 2016 5 Medication Classes That Can Interact with Warfarin http://www.pharmacytimes.com/resource-centers/afib/5-medication-classes-that-can-interact-with-warfarin Warfarin can reportedly interact with more than 100 different medications from various classes. 8:40 AM, Wed March 30, 2016 What Do Afib Patients Know About Stroke? http://www.pharmacytimes.com/resource-centers/afib/what-do-afib-patients-know-about-stroke More than 3 million individuals in the United States have atrial fibrillation, and 1 in 4 Americans will develop the condition during his or her lifetime. 9:02 PM, Thu February 25, 2016 11 Afib Risk Factors Pharmacists Should Know http://www.pharmacytimes.com/resource-centers/afib/11-afib-risk-factors-pharmacists-should-know Atrial fibrillation can be a tricky condition because patients may not know that they have it, as they may not exhibit any symptoms. 6:00 AM, Tue December 29, 2015 Direct Oral Anticoagulants for Afib: Peaks, Troughs, and Risks http://www.pharmacytimes.com/resource-centers/afib/direct-oral-anticoagulants-for-afib-peaks-troughs-and-risks Most clinicians deem treatment response variability among direct oral anticoagulants—which include direct thrombin inhibitors and factor Xa inhibitors—clinically insignificant. 8:00 PM, Mon December 21, 2015 Anticoagulant Risk-Benefit Analysis for Traveling Afib Patients http://www.pharmacytimes.com/resource-centers/afib/anticoagulant-risk-benefit-analysis-for-traveling-afib-patients With the increase in the number of patients diagnosed with atrial fibrillation or needing stroke prevention treatment, roughly 3 million Americans currently take warfarin, while a lesser number takes direct oral agents. 11:09 PM, Mon December 7, 2015 How Pharmacists Can Counsel Overweight Afib Patients http://www.pharmacytimes.com/resource-centers/afib/how-pharmacists-can-counsel-overweight-afib-patients Losing weight can help decrease the recurrence of atrial fibrillation in overweight patients. 9:30 PM, Tue November 24, 2015 Afib Patients Given Novel Oral Anticoagulant See Shorter Hospital Stays http://www.pharmacytimes.com/resource-centers/afib/afib-patients-given-novel-oral-anticoagulant-see-shorter-hospital-stays Although warfarin is time-tested, the use of novel oral anticoagulants are a topic of interest to improve health outcomes in patients with non-valvular atrial fibrillation. 9:00 PM, Wed November 18, 2015 Afib Treatment Benefits from Patient Self-Management http://www.pharmacytimes.com/resource-centers/afib/afib-treatment-benefits-from-patient-self-management Patient self-management is an emerging anticoagulation delivery model that capitalizes on patients' willingness for in-depth warfarin education to help treat their atrial fibrillation. 10:00 PM, Tue November 10, 2015 Oral Anticoagulants for Afib: Which Decision Aids Work Best? http://www.pharmacytimes.com/resource-centers/afib/oral-anticoagulants-for-afib-which-decision-aids-work-best Health care providers walk a tightrope when they employ oral anticoagulants in the treatment of atrial fibrillation. 11:00 PM, Mon October 26, 2015 Weekend Admission Doesn't Affect Afib Care http://www.pharmacytimes.com/resource-centers/afib/weekend-admission-doesnt-affect-afib-care Contrary to the findings of a previous study, patients with atrial fibrillation who are admitted to the hospital on the weekend face no greater risks than those admitted on a weekday. 8:00 AM, Thu October 22, 2015 Afib and Heart Failure: A Concomitant Conundrum http://www.pharmacytimes.com/resource-centers/afib/afib-and-heart-failure-a-concomitant-conundrum Patients with concomitant atrial fibrillation (AF) and heart failure (HF) face worse symptoms, poorer prognoses, and different treatment responses than those with either condition alone. 8:00 AM, Sun October 11, 2015 What Promotes Dementia in Atrial Fibrillation Patients? http://www.pharmacytimes.com/resource-centers/afib/what-promotes-dementia-in-atrial-fibrillation-patients Why are anticoagulated atrial fibrillation patients at higher risk of developing dementia? 8:00 AM, Tue September 29, 2015 Gout Means Greater Risk for Atrial Fibrillation http://www.pharmacytimes.com/resource-centers/afib/gout-means-greater-risk-for-atrial-fibrillation Gout patients may be at greater risk for atrial fibrillation. 9:00 PM, Tue September 8, 2015 Half of Atrial Fibrillation Patients Discontinue Warfarin http://www.pharmacytimes.com/resource-centers/afib/half-of-atrial-fibrillation-patients-discontinue-warfarin More than half of atrial fibrillation patients discontinue or interrupt warfarin therapy within 1 year of starting treatment. 10:00 PM, Sat August 29, 2015 Cardiac Clot Formation Unique in Atrial Fibrillation-Related Stroke http://www.pharmacytimes.com/resource-centers/afib/cardiac-clot-formation-unique-in-atrial-fibrillation-related-stroke Approximately 1 in 4 individuals will develop atrial fibrillation. Most disconcerting is their potential for hemorrhagic and ischemic stroke, as this risk increases up to 5-fold in AF patients. 9:00 PM, Mon August 24, 2015 How Community Pharmacists Can Screen for Atrial Fibrillation http://www.pharmacytimes.com/resource-centers/afib/how-community-pharmacists-can-screen-for-atrial-fibrillation When a screening program is proposed, policymakers have some questions: does screening improve detection of the target diagnosis; is systematic screening better than opportunistic identification? 10:00 PM, Mon August 10, 2015 NOAC Prescriptions: What Pharmacists Need to Know http://www.pharmacytimes.com/resource-centers/afib/noac-prescriptions-what-pharmacists-need-to-know Non-vitamin K antagonist oral anticoagulants are increasingly being prescribed to prevent and treat venous thromboembolism and avert stroke in patients with atrial fibrillation. 12:00 AM, Thu July 23, 2015 Bridging Raises Bleeding Risk in Atrial Fibrillation Patients on Warfarin http://www.pharmacytimes.com/resource-centers/afib/Bridging-Raises-Bleeding-Risk-in-Atrial-Fibrillation-Patients-on-Warfarin A practice-changing study suggests bridging anticoagulation does more harm than good in atrial fibrillation (AF) patients treated with warfarin. 1:42 AM, Mon June 29, 2015 Care Transitions in Anticoagulated Patients: The Health-System Pharmacist's Role http://www.pharmacytimes.com/resource-centers/afib/Care-Transitions-in-Anticoagulated-Patients-The-Health-System-Pharmacists-Role Health-system pharmacists can play a pivotal role in ensuring medication adherence among anticoagulated patients during transitions of care. 11:00 PM, Tue June 16, 2015